scholarly article | Q13442814 |
P2093 | author name string | Y Yarden | |
R Pinkas-Kramarski | |||
H Waterman | |||
M Sela | |||
E J van Zoelen | |||
A E Lenferink | |||
E Tzahar | |||
L N Klapper | |||
M J van Vugt | |||
M L van de Poll | |||
P2860 | cites work | Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3 | Q24309266 |
A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor | Q24648517 | ||
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene | Q27860693 | ||
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation | Q28131755 | ||
SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins | Q28131774 | ||
Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2 | Q28279061 | ||
Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas | Q28287906 | ||
The MAPK signaling cascade | Q28292599 | ||
Epidermal growth factor-related peptides and their receptors in human malignancies | Q28293442 | ||
Vulval development in Caenorhabditis elegans | Q28305017 | ||
The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4 | Q28513922 | ||
The cellular response to neuregulins is governed by complex interactions of the erbB receptor family | Q28609130 | ||
ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms | Q28609136 | ||
Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions | Q28609149 | ||
ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer | Q28678776 | ||
The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells | Q28678816 | ||
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer | Q29547699 | ||
ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling | Q33886341 | ||
Bivalence of EGF-like ligands drives the ErbB signaling network | Q33887274 | ||
Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships | Q34045509 | ||
Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor-alpha and epidermal growth factor | Q34181051 | ||
Monensin interrupts the recycling of low density lipoprotein receptors in human fibroblasts | Q34252494 | ||
Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body | Q34330127 | ||
Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells | Q34353519 | ||
Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis | Q34431223 | ||
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity | Q35684026 | ||
ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor | Q36653753 | ||
Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes | Q36745372 | ||
Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines | Q37611813 | ||
A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway | Q37634563 | ||
Alternative intracellular routing of ErbB receptors may determine signaling potency | Q38337018 | ||
Characterization of degP, a gene required for proteolysis in the cell envelope and essential for growth of Escherichia coli at high temperature | Q39948895 | ||
The biology of erbB-2/neu/HER-2 and its role in cancer | Q40567924 | ||
Receptor protein-tyrosine kinases and their signal transduction pathways | Q40611453 | ||
A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling | Q40673334 | ||
Endocytosis of growth factor receptors | Q40857015 | ||
Superagonistic behaviour of epidermal growth factor/transforming growth factor-alpha chimaeras: correlation with receptor routing after ligand-induced internalization | Q41044389 | ||
Biological activities of EGF-receptor mutants with individually altered autophosphorylation sites | Q41092861 | ||
Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations. | Q41175866 | ||
Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities | Q41216128 | ||
Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha | Q41225764 | ||
Requirement for neuregulin receptor erbB2 in neural and cardiac development | Q41269625 | ||
Activation of p70/p85 S6 kinase by a pathway independent of p21ras | Q41441452 | ||
The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired. | Q41518562 | ||
The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions | Q41554100 | ||
Biosynthesis of the epidermal growth factor receptor in A431 cells | Q41564487 | ||
The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. | Q41717039 | ||
The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands | Q41738022 | ||
Ligand-induced transformation by a noninternalizing epidermal growth factor receptor | Q41743656 | ||
Role of acidic intracellular compartments in the biosynthesis of Dictyostelium lysosomal enzymes. The weak bases ammonium chloride and chloroquine differentially affect proteolytic processing and sorting | Q41946234 | ||
Rapid constitutive internalization and externalization of epidermal growth factor receptors in isolated rat hepatocytes. Monensin inhibits receptor externalization and reduces the capacity for continued endocytosis of epidermal growth factor | Q41947153 | ||
Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts | Q42797529 | ||
Identification of the high affinity binding site of transforming growth factor-alpha (TGF-alpha) for the chicken epidermal growth factor (EGF) receptor using EGF/TGF-alpha chimeras. | Q42800534 | ||
Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors | Q42805800 | ||
Engineering epidermal growth factor for enhanced mitogenic potency | Q42806339 | ||
erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells | Q42807469 | ||
Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. | Q42811529 | ||
Transforming growth factor-beta and retinoic acid modulate phenotypic transformation of normal rat kidney cells induced by epidermal growth factor and platelet-derived growth factor | Q42812091 | ||
All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired | Q42816057 | ||
Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product | Q42833317 | ||
Attenuated processing of epidermal growth factor in the face of marked degradation of transforming growth factor-alpha. | Q43513067 | ||
Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor | Q43932368 | ||
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation | Q44611984 | ||
Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes | Q46371284 | ||
Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies | Q46979793 | ||
Resistance to receptor-mediated degradation of a murine epidermal growth factor analogue (EGF-Val-47) potentiates its mitogenic activity. | Q54311816 | ||
The pathway to signal achievement | Q59067952 | ||
Sequential processing of epidermal growth factor in early and late endosomes of rat liver | Q68293149 | ||
Fusions to staphylococcal protein A | Q68532056 | ||
An exact general analysis of ligand binding displacement and saturation curves | Q70765000 | ||
Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins | Q71124118 | ||
A comparison of epidermal growth factor receptor-mediated mitogenic signaling in response to transforming growth factor alpha and epidermal growth factor in cultured fetal rat hepatocytes | Q71673054 | ||
Epidermal growth factor behaves as a partial agonist in hepatocytes: effects on DNA synthesis in primary culture and competition with transforming growth factor alpha | Q71779636 | ||
A single amino acid exchange, Arg-45 to Ala, generates an epidermal growth factor (EGF) mutant with high affinity for the chicken EGF receptor | Q72055027 | ||
Molecular and clinical aspects of the Neu/ErbB-2 receptor tyrosine kinase | Q72771515 | ||
Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu | Q73174660 | ||
Intraendosomal degradation of transforming growth factor alpha | Q73195097 | ||
A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors | Q73359246 | ||
Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2 | Q73932188 | ||
The interaction of an epidermal growth factor/transforming growth factor alpha tail chimera with the human epidermal growth factor receptor reveals unexpected complexities | Q95793023 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3385-3397 | |
P577 | publication date | 1998-06-01 | |
P1433 | published in | The EMBO Journal | Q1278554 |
P1476 | title | Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers | |
P478 | volume | 17 |